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A PROSPECTIVE STUDY ON THE DIAGNOSTIC YIELD OF LOWER 
GASTROINTESTINAL ENDOSCOPY FOR ALTERED BOWEL HABITS, 
LOWER ABDOMINAL PAIN AND RECTAL BLEEDING
ABSTRACT
INTRODUCTION
Over the last two decades, there has been a remarkable advancement in 
gastrointestinal endoscopy, and lower gastrointestinal endoscopy (colonoscopy and 
sigmoidoscopy) has become the most commonly performed procedure for the 
diagnosis and treatment of diseases of the large intestine as well as screening for 
malignancy.The demand for lower GI endoscopy has been increasing over the 
years, given the relative safety and low complication rates.The diagnostic yield of 
an endoscopic procedure is defined as its capacity for identifying a lesion that is 
potentially important to patient care.
AIM AND OBJECTIVES OF THE STUDY
1. To evaluate the spectrum of clinical findings in lower gastrointestinal 
endoscopy in patients presenting with altered bowel habits, bleeding per 
rectum and abdominal pain and to evaluate its diagnostic yield. 
2. To analyze the symptomatology in colorectal carcinoma.
MATERIALS AND METHODOLOGY
The 100 patients presenting with lower GI symptoms such as bleeding p/r, 
lower abdominal pain and altered bowel habits are subjected to lower GI 
endoscopy. The findings in the colonoscopy or sigmoidoscopy are recorded. The 
diagnostic yield of the procedure for the particular indication is calculated.
RESULTS
The diagnostic yield of lower GI endoscopy in our study is as high as 44%, 
whereas the complication rate of diagnostic endoscopy is almost nil except minor 
abdominal discomfort. The diagnostic yield for colorectal cancer is highest for 
patients presenting with multiple lower GI symptoms. Rectal bleed is the most 
common presenting symptom in colorectal malignancy.
CONCLUSION
From this study we conclude that lower GI endoscopy is mandatory in 
patients presenting with multiple lower GI symptoms and bleeding per rectum; and 
screening with sigmoidoscopy should preferably be considered in patients 
presenting with common diseases of the anorectum. In patients presenting with low 
yield symptoms, judicious decision making is required to either subject the patient 
to endoscopy or other less invasive investigations. 
KEYWORDS: Colonoscopy, sigmoidoscopy, diagnostic yield
INTRODUCTION
Colorectal cancer ranks third as the most common malignancy in 
the United States and represents the second leading cause of cancer-
related mortality; approximately 147,000 patients are diagnosed with 
colorectal cancer each year and 57,000 deaths are attributed to this 
disease.1, 2 The incidence rates of rectal cancer are disproportionately 
higher in rural India.3 The variation of the incidence rates of colorectal 
cancer across India is limited unlike the striking north south differences 
in the incidence rates of stomach cancer and gall bladder cancer. The 
population based time trend studies show a rising trend in the incidence 
of colorectal cancer in India; worrisome is the finding that the incidence 
rates of colorectal cancer in Indian immigrants to the United Kingdom 
and USA are much higher, suggesting that life styles and dietary habits 
are important in the causation of the colorectal cancer; means that with 
economic transition from a low income to middle income economy 
there will be a big increase in the burden of CRC in India.3
It is imperative to screen for and detect colorectal cancer early to 
prevent morbidity and mortality. In the last two decades there has been 
an overwhelming improvement in gastrointestinal endoscopy. Lower 
gastrointestinal endoscopy has become the commonest procedure for the 
diagnosis of diseases of the large intestine. It has become the most 
accurate investigating tool in the workup and screening of patients with 
lower gastrointestinal symptoms. Given the relative safety and the easy 
availability of colonoscopy, has also led to an inappropriate referral and 
overuse of this procedure. The reported range for inappropriate referral 
and use of lower gastrointestinal endoscopies is found to be between 
15% and 35% in different studies. Several consensus based reports and 
other studies by expert panels have come up with guidelines for 
appropriate use of both upper and lower gastrointestinal endoscopies. 
The American Society for Gastrointestinal Endoscopy (ASGE) has 
developed guidelines for appropriate use of lower gastrointestinal 
endoscopies and periodically reviews the guidelines on the appropriate 
use of these procedures with frequent updates.6
The diagnostic yield of an endoscopic procedure for a specified 
indication is defined as its ability for identifying a pathological lesion 
that is potentially important for the diagnosis and treatment.17 It has 
been reported for both upper and lower gastrointestinal endoscopy in 
relation to the appropriateness of the indication. For lower 
gastrointestinal endoscopy (sigmoidoscopy and colonoscopy) it has 
been reported to be ranging between 40-45% for procedures that are 
referred for appropriate indications and 15-20% for those with 
inappropriate indications as per the ASGE guidelines.6
Though the lower gastrointestinal endoscopic procedures are 
relatively safe, it is not without complications.20 It also requires 
specialised skills to perform the procedure. Therefore it should be done 
in patients in whom it gives necessary information and aids in further 
treatment and there should be a selection criteria to validate the use of 
lower gastrointestinal endoscopy to maximize its benefits and minimize 
its inappropriate use. The aim of this study is to evaluate the diagnostic 
yield of common lower gastrointestinal symptoms for appropriate use of 
endoscopic services and to screen and detect colorectal malignancies at 
the earliest.
REVIEW OF LITERATURE
HISTORY OF COLONOSCOPY
"Over the course of decades in clinical practice, examining 
literally hundreds of thousands of people as a gastrointestinal 
endoscopist, I have learned that when a person's gastrointestinal system 
is clean, that person’s body is easily able to fight off diseases of 
whatever type."
-Dr. Hiromi Shinya
Figure 1 Dr. Hiromi Shinya with his fibro-optic colonoscopy
In 1969, a young Japanese gastroenterologist at Beth Israel 
Hospital in New York City Dr. Hiromi Shinya developed the equipment 
& technique to endoscopically remove polyps; avoiding what before 
then meant major abdominal surgery.  It was an historic breakthrough 
in the prevention of colon cancer.4, 5
Dr. William Wolff and Dr. Hiromi Shinya pioneered the 
development of complete lower gastrointestinal endoscope called the 
colonoscope. Their invention in 1969 was an advancement over the 
barium enema and the flexible sigmoidoscope as it allowed for the 
visual examination from the entire large intestine. Wolff and Shinya 
published their early evidences to overcome the skepticism about the 
device’s safety and efficacy.4, 5 Once the basic technology of the 
colonoscope had been accepted, the device lent itself to adaptations that 
have bettered its performance, and broadened its applications; the use of 
colonoscopy to screen and diagnose colorectal cancer continued to rise. 
Importantly the significance of the test has been to permit an 
understanding of colorectal cancer through the collection of biopsies 
and to lower mortality of colorectal malignancy through screening and 
early diagnosis.
ANATOMY 
The colon is described as the gastrointestinal segment that 
extends from the ileocecal valve to the rectum. The location of the colon 
in the peritoneal cavity greatly varies based on individual shape and 
extent of mesenteric attachment. The hepatic flexure lies lower than the 
splenic flexure, as can be seen on barium enema. The ascending and 
descending colons are retroperitoneally located, whereas the transverse 
and sigmoid colons have mesenteries. The length of the colon ranges 
between 120 and 200 cm and it varies with individuals. Women had a 
longer colon than men, with a median of 155 versus 145 cm and also 
women have a longer transverse colon, which also carries an increased 
likelihood of location within the pelvis. These anatomic variations 
explain why colonoscopies are generally more difficult to perform in 
women than in men. 
Three distinctive basic macroscopic features in the colon help 
differentiate it from the small bowel: 
 Presence of taeniae coli
 Presence of haustra coli
 Appendices epiploicae, or fatty appendices 
Figure 2 GROSS ANATOMY AND VASCULATURE OF THE COLON
The taeniae coli are condensations into three bundles of the 
longitudinal muscular layer of the large bowel, that are macroscopically 
visible, although a thinner longitudinal layer remains to completely 
encircle the lumen. Taeniae extend from the cecum to the end of the 
sigmoid. The taeniae contribute to the configuration of the haustra as 
convex folds of colonic wall which renders colon its saccular 
appearance. The appendices epiploicae are like droplets of yellow 
adipose tissue surrounding the colonic wall. They are prominent in the 
sigmoid, and they become absent in the rectum.
Caecum
The caecum is the proximal portion of the colon after the 
ileocecal valve and it continues into the ascending colon. It measures 
approximately 6 cm in length and 7.5 to 8 cm in width. The cecum is 
generally covered by peritoneum, although in most cases, there is no 
distinct mesentery and the mobility is limited. The lowest haustrum 
corresponds to caecal fundus which can be endoscopically viewed, 
where the appendiceal orifice is usually visible and is a useful indicator 
of a complete colonoscopic exploration. A mucosal fold known as 
Gerlach's valve rarely covers the appendiceal orifice. A landmark 
visible endoscopically is the ileocecal valve, with the ileal orifice 
delimited by two distinct lips such as the ileocolic and the ileocecal lip. 
Appendix 
The vermiform appendix is in continuation with the cecum 
through the appendiceal orifice which is surrounded by a continuous 
longitudinal muscular layer; which results from the union of the three 
taeniae. It is 8 to 9 cm long and it can range from 5 to 35 cm. In 
approximately 65% of patients, the appendix courses vertically in the 
retrocecal recess and in 31%, it descends into the iliac fossa or it can be 
encountered in a paracecal, preileal, or postileal location. The appendix 
is accompanied by its corresponding mesoappendix, which contains the 
appendicular artery, a terminal artery without any arterial arcades. The 
venous drainage is to the ileocolic and the right colic veins and the 
lymphatics drain into the ileocecal nodes and then along the SMA nodes 
into the celiac nodes.
Ascending Colon 
The ascending colon lies on the right side of the abdomen in front 
of the quadratus lumborum and transversus abdominis muscle. It 
extends from the cecum to the hepatic flexure. On an average it 
measures 12 to 20 in length. Mostly, the ascending colon is covered by 
peritoneum on its anterior and lateral aspects and is fixed posteriorly. 
Uncommonly, a tenuous adhesion from the right abdominal wall to the 
anterior taeniae of the ascending colon has been observed, which is 
referred to as Jackson's membrane. In the lower margin of the liver and 
lateral to the gallbladder, the ascending colon turns to the left and this 
point is known as hepatic flexure. The hepatic flexure lies above the 
second portion of the duodenum and it is sometimes attached by a 
peritoneal fold referred to as duodenocolic ligament.
Transverse Colon 
The transverse colon connects the ascending and descending 
colon. It courses horizontally across the abdominal cavity and it is 
attached to the posterior abdominal wall by a long mesentery, which 
renders it extremely flexible. The transverse colon is quite long, 40 or 
50 cm and sometimes it can reach the iliac crests or even lie deep into 
the pelvis. The duodenojejunal junction, known as the ligament of 
Treitz, lies just inferior to the root of the transverse mesocolon. The 
greater omentum covers the transverse colon almost it’s entire length 
and is connected to it by the gastrocolic ligament. The splenic flexure 
lies higher than the contralateral hepatic flexure and is connected by 
flimsy adhesions to the lower pole of the spleen, which contributes to 
render it a fixed bowel segment. This anatomic location is often difficult 
to access and makes the spleen at increased risk of inadvertent tears 
during surgical dissection of the splenic flexure. 
Descending Colon 
The descending colon extends from the left upper quadrant to the 
pelvic brim. It connects the splenic flexure to the sigmoid colon and It 
measures approximately 30 cm and descends vertically and slightly 
toward the midline in the groove between the psoas and the quadratus 
lumborum. It is surrounded by the peritoneum anteriorly and bilaterally, 
whereas in most cases and it is fixed on the posterior peritoneum 
through the Toldt fascia and this is an important surgical plane to allow 
for a bloodless dissection. 
Sigmoid Colon 
The sigmoid colon starts at the pelvic brim at the point where the 
descending colon turns medially.  It terminates at the level of the sacral 
promontory where the three taeniae commonly coalesce into a diffuse 
longitudinal muscular layer devoid of any epiploicae. The presence of a 
distinct sigmoido-rectal sphincter is generally not recognized, even 
though Shafik and colleagues have identified distinct, thickened smooth 
muscle bundles at the junction of sigmoid and rectum. The diameter of 
the sigmoid colon decreases along its course. Its long mesocolon with a 
short base predisposes to the onset of sigmoid volvulus. A long 
convoluted sigmoid has been implicated in the origin of constipation. 
The mesosigmoid contains a recess known as the intersigmoid fossa,
which can be used as a landmark for identification of the ureter. 
Arterial Blood Supply 
The vascular supply of the colon is variable. It receives its blood 
supply from both the SMA and the inferior mesenteric artery (IMA) 
systems; the branches of each system and the connections between the 
two systems are variable.
The SMA system supplies the right and the proximal transverse 
colon; the IMA system sends tributaries to the distal transverse, 
descending, and sigmoid colon.
The marginal artery of Drummond goes in close proximity and 
parallel to the bowel wall. It is variably anastomosed to the terminal 
portions of the named colic trunks as well as peripheral branches and 
gives origin to the terminal vasa recta that directly supply the bowel 
wall. The marginal artery is less consistently encountered at the level of 
the splenic flexure, where the vascular arcades connecting the MCA and 
LCA are often absent, in a critical colonic segment that has been 
described as the Griffith's point. It has been suggested that an 
inconsistent marginal artery might also enhance a more tenuous vascular 
supply at the junction of the lowest sigmoid branch and the superior 
hemorrhoidal artery, referred to as Sudek's point.
The meandering artery or A
branch that can seen occasionally;  it connects the proximal MCA to the 
LCA and runs in the transverse mesocolon parallel to the left branch of 
the MCA.
Venous Return 
The venous return generally corresponds to the arterial supply. 
The right side of the colon drains into the SMV and from there into the 
portal vein; the left colon drains into the IMV and from there drains into 
the splenic vein and only then into the porta
appendix drain into the ileocolic vein, which is a tributary of the SMV. 
Figure 3 VENOUS DRAINAGE OF THE COLON
rc of Riolan is an additional collateral 
l system. The cecum and the 
Lymphatic Drainage 
Colonic lymphatics are divided into four drainage levels. The 
lymphatic plexuses located on the bowel wall drain first into the epicolic 
nodes which are located in the epiploic appendages and subserosally. 
The lymphatics from the epiploic nodes then drain into the paracolic 
nodes which are located behind the peritoneum on the upper border of 
the transverse and on the mesenteric side of the remaining colon. The 
intermediate nodes which are the third lymphatic station are 
encountered along the course of the main colonic vessels, the ICA, 
RCA, MCA, LCA, and sigmoid branches. The intermediate nodes 
ultimately drain into the lymph nodes along the two main colonic 
tributaries, the SMA and IMA; from these two main trunks the 
lymphatic drainage continues into the iliolumbar chain and terminates 
into the thoracic duct. 
Figure 
INVESTIGATIONS AND EVALUATION OF DISEASES OF THE 
ANAL CANAL, RECTUM AND COLON
The appropriate treatment of diseases of the colon, rectum, and 
anus relies on a correct diagnosis which is built on three pillars 
history, examination, and investigation. To take a good accurate and 
targeted history; and to perform a careful and revealing physical 
examination; and to choose the right investigations requires great skill 
and acumen. This wisdom comes with exper
in perfecting these diagnostic techniques. Clinical diagnostic skills have 
been less valued as part of a diagnostic work
4 LYMPHATIC DRAINAGE
ience and it is of great value 
-up since the early 1980s; 
such as 
as easy access to a world of imaging techniques has tended to encourage 
taking “the easy way out.” As clinicians, we are asked to account for the 
costs of every investigation; so we are reminded to begin with as 
thorough a clinical assessment as possible to save expensive 
investigative tests for well-defined indications. We need to ask the right 
questions of our patients; and know what to look for on examination; 
and how to look for it; and choose only tests that will make a difference.
HISTORY 
General Principles of history taking
The history of a patient can be the key to the diagnosis of any 
disease, particularly of the colon, rectum and anal canal. When the 
patient describes symptoms we should assess the likely site and nature 
of the problem; and direct the remainder of the history. To keep one’s 
mind open is important though, as a patient may use his own diagnostic 
terminology in a lay application and misguide the clinicians in 
diagnosing his condition. For example, when a patient says he has 
“hemorrhoids” could mean any ano-rectal diseases such as rectal 
prolapsed perianal abscess or fissure in ano. Basic history-taking skills 
are important; and are refined by a mental differential diagnosis that 
impels specific questions. An astute clinician should take detailed 
history about the patient's bowel habits, dietary habits, and use of any 
medications. Apart from the history should also include details about the 
presenting complaint; the comorbid diseases; the medications that are 
used over-the-counter, drug allergies and intolerances, previous 
operations; and history of related diseases or colorectal cancer in the 
family members. History must also include inquiry about the sexual 
habits as it is related to many anal and rectal diseeases. After a thorough 
history the probable differential diagnosis should be fairly well 
established which should then guide further clinical examination and 
necessary relevant investigations to confirm or exclude some of the 
possible diagnoses and to exclude other common complicating 
conditions.
Symptoms 
 Bleeding
 Anorectal Pain, Itching, and/or Swelling
 Abdominal Pain and/or Distention
 Constipation
 Diarrhea
 Urgency and Incontinence
EXAMINATION 
General Principles
Patients with a disease of the lower gastrointestinal tract bear the 
burden of embarrassment in addition to concerns about their symptoms, 
diagnosis, and prognosis. They expect a professional attitude; 
consideration to covering sensitive areas where possible; and a minimal 
number of observers in the room. A same gender nurse should be 
present during the examination. Gentle examination is paramount to 
minimizing discomfort, especially when performing anal examinations. 
Maximum information can be obtained only if the patient is able to 
tolerate the examination and relax. Anoscopy and proctosigmoidoscopy 
allows visual evaluation.
Position 
Most patients undergo anorectal examination in the prone 
jackknife or left lateral decubitus position. The patient is covered with a 
sheet; lying in the left lateral decubitus (Sims') position; the hips and 
knees are flexed; and the patient's hips are positioned on the edge of the 
table. The head, knees, and feet are situated opposite the examiner, 
angling the patient's body across the table. The perineum is then 
undraped to allow isolated exposure of the examination area.
Figure 5 PATIENTS' POSITION FOR CLINICAL EXAMINATION OF RECTUM 
Inspection and Palpation 
Examination of the perineum and anus must be systematic. The 
examiner should position himself on opposite side of the patient and 
then gently separate the butt
dominant hand free. The sacrococcygeal region is inspected to exclude 
pilonidal disease. The skin changes are then inspected, for abnormalities 
AND ANAL CANAL
ocks; with the examiner leaving his or her 
that include excoriation, maceration, ulceration, drainage sites, lesions, 
and masses. The perianal region is observed for external hemorrhoids, 
skin tags, scarring, and deformity. Retraction allows inspection of the 
anal verge and distal canal for a fissure, ulcer, and prolapsing anal 
papillae or internal hemorrhoids. If rectal prolapse is suspected, the 
patient is asked to perform the Valsalva maneuver to look for prolapsing 
mucosa or rectal wall. 
Palpation of the perineum is performed. Presence of tenderness, 
fluctuation or induration suggets abscess. Fistula tracts can be felt as 
they course from an external opening towards the anal canal. A well-
lubricated finger is then gently and slowly inserted into the anal canal to 
assess sphincter tone. As the finger passes along the anoderm above the 
intersphincteric groove, the canal should feel smooth and nonulcerated. 
The dentate line can be felt, as the mucosa changes into more irregular 
tissue. Hypertrophied anal papillae and masses can be best appreciated 
by rotating the digit. Internal hemorrhoids are rarely palpable. The 
patient is asked to squeeze around the examining finger to assess 
external sphincter and puborectalis function. The distal rectum is 
examined last, beginning with palpation of the prostate or cervix 
through the anterior rectal wall. The rectum is circumferentially 
palpated to exclude tenderness, induration, polyps, and masses. 
INVESTIGATION 
Blood and Stool Testing
Blood and stool tests are helpful in the evaluation of some 
disorders of the large bowel and anus. Serum electrolyte abnormalities 
can affect bowel frequency with few other systemic manifestations; 
altered thyroid-stimulating hormone levels may identify the cause of 
intestinal symptoms related to thyroid dysfunction; a bleeding colorectal 
neoplasm may be the cause of a microcytic, hypochromic anemia. 
Stool tests for ova, parasites, and other pathogens can diagnose 
infectious colitides. Serum and stool tests are used in the evaluation of 
colorectal carcinoma. Serum carcinoembryonic antigen (CEA), a 
glycoprotein found in the cell membrane of cancer cells is the tumor 
marker most often used clinically. Unfortunately, CEA is not specific 
for the gut epithelium or malignant neoplasms; and is not useful as a 
screening tool. Preoperative CEA levels herald postoperative disease 
recrudescence and recurrence; an elevated preoperative level does not 
return to normal, undetected disease is suspected; if the level normalizes 
but begins to return to abnormal range, recurrence will likely be 
discovered with further investigation.
A common screening test for colorectal malignancy is guaiac-
based fecal occult blood testing, (FOBT). FOBT has been used widely 
for more than 30 years. FOBT is the only noninvasive screening test 
shown to decrease mortality from colorectal malignacy. 
Blood testing for gene abnormalities are used for persons with 
particular forms of inherited colorectal malignancies, such as familial 
adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal 
cancer (HNPCC). 
Endoscopy 
Anoscopy
Examination of the anal canal is best performed with an 
anoscope. Digital rectal examination should always precede insertion of 
the anoscope. The patient is informed of the procedure. A well-
lubricated anoscope is gently applied against the anus; and gradual 
pressure is applied to pass the scope into the canal. Difficulties are 
suggestive of sphincter spasm or anal stenosis, mandating the use of a 
smaller-caliber anoscope; or of anal pathology that necessitates 
examination under anesthesia. Once inserted, it is used to 
circumferentially inspect the anal canal and, occasionally, the lower 
rectum. The scope is withdrawn in each quadrant to allow visualization 
of all mucosa.
Rigid Proctosigmoidoscopy
Rigid endoscopy is the procedure of choice for evaluation and 
treatment of distal rectal lesions.  A rigid scope more accurately 
measures the location of a tumor relative to the anal verge than a 
flexible endoscope. The rigid instruments are 25 cm long and
diameter of 11, 15, or 19 mm. The scope is inserted after anoscopy has 
been completed; after the rigid proctosigmoidoscope has passed through 
the sphincters while typically directed toward the umbilicus, the 
Figure 6 ANOSCOPE
have a 
obturator is removed, and the scope is advanced under direct 
visualization. 
The direction of the scope is posteriorly along the sacral hollow, 
around the inferior (left posterior), middle (right anterior), and upper 
(left posterior) valves of Houston. The rectosigmoid junction will come 
into view after 17 to 19 cm; further insertion will cause many patients to 
experience crampy visceral pain that resolves with instrument 
withdrawal. The angulated rectosigmoid may appear as a blinded end to 
the rectum with no visible rectum, with gentle manipulation to the left 
and then to the right will often open the sigmoid lumen to inspection. 
Air insufflation facilitates the procedure, but excessive use is painful 
and interferes with the examination. Careful examination is performed 
during withdrawal while sweeping the scope around to inspect all 
mucosal surfaces; flattening the rectal valves to survey their cephalad 
components.
Biopsy can be done posteriorly along the folds of the valves, to 
minimize the risk of perforation. Small lesions can be fulgurated. Larger 
polyps can be excised with a Frankfeldt snare. Anterior biopsies above 
the middle rectal valve are especially prone to intraperitoneal 
perforation because this area is situated above the peritoneal reflection. 
Perforation occurs in about 0.005% to 0.
Perforation by the scope occurs at areas of angulation, bowel wall 
weakness, and intestinal fixation. Bleeding after biopsy usually ceases 
spontaneously. Explosion can occur during electrocoagulation in the 
presence of methane and 
Figure 
Flexible Proctosigmoidoscopy
Flexible proctosigmoidoscopy better tolerated and more sensitive 
in detecting distal large bowel lesions while allowing greater length of 
intestine to be inspected. The scope is advanced to the rectosigmoid, 
01% of rigid procedures. 
hydrogen gases.
7 RIGID SIMOIDOSCOPE
where passage requires a combination of torque and in
avoid loop formation that causes discomfort, precluding further 
examination. The flexible instrument is advanced with care taken to 
avoid intubation of wide
be negotiated with ease but occasionally requires the assistant to splint 
the abdominal wall to avoid looping. The flexible proctosigmoidoscope 
can be inserted to at least 50 cm.
Biopsy samples are obtained from haustral folds. 
Electrocoagulation should be avoided because of the risk of explosion. 
Perforation occurs in 0.01% of patients.
Figure 
-out motion to 
-mouthed diverticula. The descending colon can 
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Colonoscopy
Colonoscopy is the most 
benign and any malignant diseases of the colon and rectum. It can be 
used in the asymptomatic patient as screening for early neoplasm; is an 
important diagnostic tool in adenomatous, bleeding, and inflammatory 
conditions.
In the acutely bleeding patient emergency colonoscopy can 
identify the bleeding source in 70% to 92% of patients with moderate or 
severe lower gastrointestinal hemorrhage (LGIH); endoscopic 
management of LGIH can be achieved in many cases with coa
injection, and occlusion devices.
essential tool in the diagnosis of several 
Figure 9 COLONOSCOPE
gulation, 
Radiologic Tests 
 Plain Films
 Colonic Transit Study
 Single-Contrast Barium Enema
 Double-Contrast Barium Enema
 Water-Soluble Contrast Enema
 Contrast Fistulography
 Defecography
 Endoluminal Ultrasound
 CT Scanning
 CT Enterography (Virtual colonoscopy)
 MR Imaging
 Positron Emission Tomography
IMPORTANT DISEASES OF COLON, RECTUM AND ANAL 
CANAL
DIVERTICULAR DISEASE
A colonic diverticulum is an abnormal sac or pouch protruding 
from the colon. A true diverticulum has all layers of the intestinal wall; 
a false diverticulum, or pseudodiverticulum, lacks a portion of the 
normal bowel wall. The diverticula that occurs in c
of the normal muscular layers, they are pseudodiverticula.
Figure 10
Diverticulitis
Diverticulitis is the result of a perforation of a colonic 
diverticulum; it is an extra
extravasation of feces through the perforated diverticulum. The highest 
incidence of diverticula is in the sigmoid colon. It is by far the most 
frequent site for involvement with diverticulitis. Patients usually 
complain of left lower quadrant abdominal pain radiating to the 
suprapubic area, left groin, or back; alteration in bowel habit; fever, 
chills, and urinary urgency are common; rectal bleeding is not usually 
associated with an attack of diverticulitis.
olon are are devoid 
PATHOGENESIS OF DIVERTICULUM
-luminal pericolic infection caused by the 
A limited sigmoidoscopic examination may be helpful, however 
air should not be insufflated through the endoscope because of 
distention of the colon and the possibility that increased colonic pressure 
could force more bacteria through the perforation into the peritoneal
cavity. The sigmoidoscope can usually only useful to exclude a cancer 
of the rectum as a cause of the symptoms.
If the diagnosis is in doubt, four diagnostic tests can be 
considered: computed tomography (CT) of the abdomen, magnetic 
resonance imaging (MRI), abdominal ultrasound, and water-soluble 
contrast enema. Ultrasound of the abdomen has many of the advantages 
of CT, including the possibility of percutaneous drainage of an abscess 
with ultrasound guidance. 
Hinchey and Co described a practical classification system that 
provides some organization of the broad clinical spectrum of the 
disease: 
Stage I: pericolic or mesenteric abscess
Stage II: walled-off pelvic abscess
Stage III: generalized purulent peritonitis
Stage IV: generalized fecal peritonitis
Uncomplicated diverticulitis can often be treated with antibiotics on an 
outpatient basis. A first attack of uncomplicated diverticulitis is usually 
treated with antibiotic therapy, with the introduction of a high
If a patient suffers re
treatment of choice. 
Figure 
Complicated Diverticulitis
Abscess 
An abscess complicating diverticulitis is usually confined to the 
pelvis and patients presents with significant pain, fever, and 
leukocytosis. Examination may detect a tender, fluctuant mass. CT scan, 
MRI, or ultrasound will confirm the diagnosis and locat
-fiber diet. 
current attacks of diverticulitis, surgery is the 
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ion of the 
abscess. Abscess >2 cm in diameter, should be drained. The preferred 
method of drainage is a percutaneous route guided by CT or ultrasound. 
A pelvic abscess can be drained into the rectum through a transanal 
approach. Transabdominal approach by laparotomy has the risk of 
spreading the contents of the abscess throughout the peritoneal cavity 
and hence not preferred.  
Drainage of the abscess and intravenous antibiotics usually results 
in a rapid clinical improvement. A fistula may result from the sigmoid 
colon to the insertion site of the percutaneous catheter; this can be easily 
handled at the time of elective surgery when the intense intra-abdominal 
infection has subsided.
Elective surgery should be offered after the patient has 
completely recovered from the infection, usually about 6 weeks after 
drainage of the abscess; at that time, it is usually feasible to excise the 
diseased sigmoid colon and fashion an anastomosis between the 
descending colon and rectum, thus avoiding a colostomy. 
Fistula 
A fistulous communication between the sigmoid colon and the 
skin (which may result from percutaneous drainage of an abscess), 
bladder, vagina, or small bowel is a relatively frequent complication of 
diverticulitis. Symptoms of a sigmoid-vesical fistula are pneumaturia 
(passage of air from the urethra classically noted at the end of 
micturition), fecaluria, and recurring urinary tract infections. The 
investigation of choice is a CT scan, which may demonstrate air in the 
bladder. Initial treatment includes control of infection and thereby to 
reduce the associated inflammation. 
Fistulas caused by diverticulitis can usually be treated by a one-
stage operation; taking down the fistula and excising the sigmoid colon; 
and then fashioning an anastomosis between the descending colon and 
the rectum. 
Generalized Peritonitis
Generalized peritonitis resulting from diverticulitis can be due to
(1) a diverticulum perforates into the peritoneal cavity, and the 
perforation is not sealed
(2) an abscess that is initially localized expands and suddenly 
bursts into the unprotected peritoneal cavity. 
Patients present with generalized peritonitis caused by a perforated 
diverticulum; exhibit diffuse abdominal tenderness, with voluntary and 
involuntary guarding over the entire abdomen. Imaging may reveal 
intraperitoneal free air, but the absence of extraintestinal air does not 
exclude the diagnosis. Immediate laparotomy is done to identify and 
excise the segment of colon containing the perforation and Hartmann’s 
procedure is done. 
Obstruction
Intestinal obstruction associated with diverticular disease occurs 
by narrowing of the sigmoid due to the muscular hypertrophy of the 
bowel wall; or by infection and inflammation aspect of diverticulitis. 
Inflammatory Bowel Disease
Epidemiology 
Inflammatory bowel disease includes 
 Ulcerative colitis
 Crohn's disease
 Indeterminate colitis
Figure 
Pathology and Differential Diagnosis
Ulcerative colitis and Crohn's colitis share many pathologic and 
clinical similarities. In ulcerative colitis the colonic mucosa and 
submucosa are infiltrated with inflammatory cells. The mucosa may be 
atrophic and crypt abscesses are common. Colonoscopy s
mucosa is friable and may possess multiple inflammatory pseudopolyps. 
In long-standing colitis, the colon may be shortened and the mucosa 
replaced by scar. Ulcerative colitis may affect the rectum (proctitis); 
rectum and sigmoid colon (proctosigmo
(left-sided colitis); or the rectum and entire colon (pancolitis). Small 
intestine is not involved, but the terminal ileum may demonstrate 
inflammatory changes ("backwash ileitis"). A characteristic feature of 
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hows the 
iditis); rectum and left colon 
ulcerative colitis is the continuous involvement of the rectum and colon, 
whereas rectal sparing or skip lesions are characteristic of Crohn's 
disease. Patients typically presents with bloody diarrhoea, crampy 
abdominal pain and tenesmus. Severe abdominal pain and fever raises 
the concern of fulminant colitis or toxic megacolon. 
Crohn's disease is characterised by transmural inflammatory 
process that can affect any part of the gastrointestinal tract from mouth 
to anus. The characteristic histological features are mucosal ulcerations, 
an inflammatory cell infiltrate, and noncaseating granulomas. Chronic 
inflammation leads to fibrosis, strictures, and fistulas in either the colon 
or small intestine. The colonoscopic appearance of Crohn's colitis is 
deep serpiginous ulcers and a "cobblestone" appearance. Acute 
inflammation may produce diarrhea, crampy abdominal pain and fever; 
strictures may produce obstruction. Weight loss is a prominent symptom 
and it is due to obstruction and protein loss. Perianal Crohn's disease 
presents with fistulas or abscesses. 
Extraintestinal Manifestations
The liver is a common site of extraintestinal disease in 
inflammatory bowel disease characterised by fatty infiltration and 
cirrhosis of the liver. Primary sclerosing cholangitis is characterized by 
intra and extrahepatic bile duct strictures. Arthritis, E
Pyoderma gangrenosum can also occur. Ocular involvement includes 
uveitis, iritis, episcleritis, and conjunctivitis. 
Principles of Nonoperative Management
Medical management includes decreasing inflammation and 
alleviating symptoms. Mild to moderate flares may be treated in the 
outpatient setting, whereas more severe signs and symptoms mandate 
Figure 13 CROHN'S COLITIS
rythema nodosum, 
hospitalization.  Ulcerative proctitis and proctosigmoiditis are treated 
with topical application of salicylate and/or corticosteroid suppositories 
and enemas.
Salicylates
Sulfasalazine (Azulfidine), 5-ASA, and related compounds are 
first-line drugs in the medical treatment of mild to moderate 
inflammatory bowel disease. 
Antibiotics
Antibiotics are used to decrease the intraluminal bacterial load in 
Crohn's disease. Metronidazole may improve Crohn's colitis and 
perianal disease, but the evidence is weak. Fluoroquinolones can also be 
effective in some cases. 
Corticosteroids
Corticosteroids (either oral or parenteral) are used in treatment of 
acute exacerbation of either ulcerative colitis or Crohn's disease. 
Newer agents such as budesonide, beclomethasone dipropionate, 
and tixocortol pivalate undergo rapid hepatic degradation, which 
significantly decreases systemic toxicity. 
Immunosuppressive Agents
Azathioprine and 6-mercaptopurine are antimetabolite drugs that 
interfere with nucleic acid synthesis and thus decrease proliferation of 
inflammatory cells; are useful for treating ulcerative colitis and Crohn's 
disease in patients who have failed salicylate therapy; or who are 
dependent upon or refractory to corticosteroids; however, that the onset 
of action of these drugs takes 6 to 12 weeks, and concomitant use of 
corticosteroids almost always is required.
Cyclosporine is an immunosuppressive agent that is not routinely 
used to treat inflammatory bowel disease; however, up to 80% of 
patients with an acute flare of ulcerative colitis will improve with its 
use. Methotrexate is a folate antagonist that can also be used to treat 
inflammatory bowel disease; there are reports that more than 50% of 
patients will improve with administration of this drug.
Infliximab (Remicade) is a monoclonal antibody against tumor 
necrosis factor alpha; IV infusion of this agent decreases inflammation 
systemically. 
Nutrition
Patients with inflammatory bowel disease are often malnourished. 
Abdominal pain and obstructive symptoms may decrease oral intake; 
diarrhea can cause significant protein loss; ongoing inflammation 
produces a catabolic physiologic state. In extremely malnourished 
patients creation of a stoma often is safer than a primary anastomosis.
Indications for Surgery
Emergency surgery is required for patients with massive life-
threatening hemorrhage, toxic megacolon and fulminant colitis. Patients 
with should be treated aggressively with bowel rest, hydration, broad-
spectrum antibiotics, and parenteral corticosteroids; colonoscopy and 
barium enema are contraindicated; and antidiarrheal agents should be 
avoided. Any deterioration in clinical condition or failure to improve 
within 24 to 48 hours mandates surgery.
Indications for elective surgery are intractability despite maximal 
medical therapy and development of major complications of medical 
therapy. Elective surgery is also indicated in patients at significant risk 
of developing colorectal carcinoma. 
In Crohn's disease, it is impossible to remove the entire at-risk 
intestine; therefore, surgical therapy is reserved for complications of the 
disease.  Several principles should guide intraoperative decision 
making; a laparotomy for Crohn's disease should be done through a 
midline incision because of the possible need for a stoma; because many 
patients with Crohn's disease will require multiple operations, the length 
of bowel removed should be minimized; bowel should be resected to an 
area with grossly normal margins; a primary anastomosis may be safely 
created if the patient is medically stable, nutritionally replete, and taking 
few immunosuppressive medications. Creation of a stoma should be 
strongly considered in any patient who is hemodynamically unstable, 
septic, malnourished or receiving high-dose immunosuppressive therapy 
and in patients with extensive intra-abdominal contamination.
Anal and Perianal Crohn's Disease
Anal or perianal disease occurs in 35% of all patients with 
Crohn's disease; isolated anal Crohn's disease is uncommon, affecting 
only 3 to 4% of patients so detection of anal Crohn's disease, therefore, 
should prompt evaluation of the remainder of the GI tract.
The most common perianal lesions in Crohn's disease are skin 
tags that are minimally symptomatic. Fissure in ano is also common. 
Perianal abscess and fistulas are common; and can be particularly 
challenging. They complex and often have multiple tracts. Treatment of 
perianal Crohn's disease focuses on alleviation of symptoms. In general, 
skin tags and hemorrhoids should not be excised unless they are 
extremely symptomatic because there is risk of creating chronic, 
nonhealing wounds. 
Recurrent abscess or complex anal fistulas should raise the 
possibility of Crohn's disease. Treatment includes control of sepsis, 
delineation of complex anatomy, treatment of underlying mucosal 
disease, and sphincter preservation. Proinflammatory cytokines such as 
interleukin-12 and interferon are potential targets. 
Adenocarcinoma and Polyps
Incidence
Colorectal carcinoma is the most common malignancy of the GI 
tract; over 150,000 new cases are diagnosed annually in the United 
States; and more than 52,000 patients die of this disease each year, 
making colorectal cancer the second most common cause of cancer 
death in the United States. The incidence is similar in men and women. 
Early detection by screening methods and improvements in medical and 
surgical care are thought to be responsible for the decreasing mortality 
of colorectal cancer observed in recent years.
Epidemiology (Risk Factors)
Identification of risk factors for development of colorectal cancer 
is essential to establish screening and surveillance programs in 
appropriately targeted populations.
Aging
Aging is the most important risk factor for colorectal cancer, with 
incidence rising steadily after age 50 years. 
Hereditary Risk Factors
Approximately 80% of colorectal cancers occur sporadically and 
20% arise in patients with a known family history of colorectal cancer. 
Environmental and Dietary Factors
Diets high in animal fat and low in fibre contribute to 
carcinogenesis. In contrast, a diet high in vegetable fibre appears to be 
protective. Ingestion of calcium, selenium, vitamins A, C, and E, 
carotenoids, and plant phenols have shown to decrease the risk of 
developing colorectal cancer. Obesity and sedentary lifestyle also 
increase cancer-related mortality in colorectal carcinoma.
Inflammatory Bowel Disease
Patients with long-standing colitis from inflammatory bowel 
disease are at increased risk for the development of colorectal cancer; 
other factors thought to increase risk include the presence of primary 
sclerosing cholangitis and family history of colorectal cancer. In 
ulcerative colitis, the risk of malignancy is approximately 2% after 10 
years, 8% after 20 years, and 18% after 30 years; patients with Crohn's 
pancolitis have similar risk. 
Other Risk Factors
Cigarette smoking is associated with an increased risk of colonic 
adenomas. Patients undergone ureterosigmoidostomy are also at 
increased risk for both adenoma and carcinoma formation. Acromegaly 
is associated with increased levels of circulating human growth 
hormone and insulin-like growth factor I, increases risk for colorectal 
carcinoma. 
Polyps
The majority of colorectal carcinomas evolve from adenomatous 
polyps; this sequence of events is the 
Polyp is a nonspecific clinical term that describes any projection from 
the surface of the intestinal mucosa regardless of its 
Colorectal polyps may be classified as 
 neoplastic (tubular adenoma
adenomas) 
 hamartomatous (
 inflammatory (pseudopolyp
 hyperplastic
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Figure 17 HAGGITT'S CLASSIFICATION OF TUMOR INVASION IN 
PEDUNCULATED OR SESSILE POLYP
Three operative procedures can be considered: total 
proctocolectomy with either an end (Brooke) ileostomy or continent 
(Kock) ileostomy; total abdominal colectomy with ileorectal
anastomosis; and restorative proctocolectomy with ileal pouch
anastomosis with or without a temporary ileostomy. The administration 
of COX-2 inhibitors (celecoxib, sulindac) has shown to slow or prevent 
the development of polyps.
–anal 
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FAP may be associated with extraintestinal manifestations such 
as congenital hypertrophy of the retinal pigmented epithelium, desmoid 
tumors, epidermoid cysts, mandibular osteomas (Gardner's syn
and central nervous system tumors (Turcot's syndrome). 
Hereditary Nonpolyposis Colon Cancer (Lynch Syndrome)
HNPCC (or Lynch syndrome) is also rare (1 to 3%). The genetic 
defects associated with HNPCC arise from errors in 
HNPCC is inherited in an autosomal dominant pattern; and is 
characterized by the development of colorectal carcinoma at an early 
age (average age: 40 to 45 years). About 70% of affected individuals 
will develop colorectal cancer. The risk of synchronous 
mismatch repair
drome); 
. 
or 
metachronous colorectal carcinoma is 40%. HNPCC is associated with 
extracolonic malignancies, including endometrial, which is most 
common, ovarian, pancreas, stomach, small bowel, biliary, and urinary 
tract carcinomas. The Amsterdam criteria for clinical diagnosis of 
HNPCC are three affected relatives with histologically verified 
adenocarcinoma of the large bowel (one must be a first-degree relative 
of one of the others) in two successive generations of a family with one 
patient diagnosed before age 50 years. 
Screening colonoscopy is recommended annually for at-risk 
patients beginning at either age 20 to 25 years or 10 years younger than 
the youngest age at diagnosis in the family, whichever comes first. 
Because of the high risk of endometrial carcinoma, transvaginal 
ultrasound or endometrial aspiration biopsy should be done annually 
after age 25 to 35 years. There is a 40% risk of developing a second 
colon cancer, so total colectomy with ileo-rectal anastomosis is 
recommended once adenomas or a colon carcinoma is diagnosed, or if 
prophylactic colectomy is decided upon. Prophylactic hysterectomy and 
bilateral salpingo-oophorectomy should be considered in women who 
have completed childbearing.
Familial Colorectal Cancer
Nonsyndromic familial colorectal cancer accounts for 10 to 15% 
of patients with colorectal cancer. Screening colonoscopy is 
recommended every 5 years beginning at age 40 years or beginning 10 
years before the age of the earliest diagnosed patient in the pedigree. 
Prevention: Screening and Surveillance
Advantages and Disadvantages of Screening Modalities for 
Asymptomatic Individuals
Advantages Disadvantages
Fecal occult blood 
testing
Ease of use and 
noninvasive
May not detect most 
polyps
Low cost Low specificity 
Good sensitivity with 
repeat testing
Colonoscopy required 
for positive result
Poor compliance with 
serial testing
Sigmoidoscopy Examines colon most at 
risk
Invasive
Very sensitive for 
polyp detection in left 
colon
Uncomfortable
Slight risk of 
perforation or bleeding
Does not require full 
bowel preparation 
(enemas only)
May miss proximal 
lesions
Colonoscopy required if 
polyp identified
Colonoscopy Examines entire colon Most invasive
Highly sensitive and 
specific
Uncomfortable and 
requires sedation
Therapeutic Requires bowel 
preparation
Risk of perforation or 
bleeding
Costly
Double-contrast 
barium enema
Examines entire colon Requires bowel 
preparation
Good sensitivity for 
polyps >1 cm
Less sensitivity for 
polyps <1 cm 
May miss lesions in the 
sigmoid colon 
Colonoscopy required 
for positive result
Computed 
tomographic 
colonography 
(virtual colonoscopy)
Examines entire colon Requires bowel 
preparation
Noninvasive Insensitive for small 
polyps 
Sensitivity may be as 
good as colonoscopy
Minimal experience and 
data
Colonoscopy required 
for positive result
Costly
Screening Guidelines for Colorectal Cancer
Population Initial Age Recommended Screening Test
Average risk 50 y Annual FOBT or
Flexible sigmoidoscopy every 5 
y or
Annual FOBT and flexible 
sigmoidoscopy every 5 y or
Air-contrast barium enema 
every 5 y or
Colonoscopy every 10 y
Adenomatous 
polyps
50 y Colonoscopy at first detection; 
then colonoscopy in 3 y
If no further polyps, 
colonoscopy every 5 y
If polyps, colonoscopy every 3 y
Annual colonoscopy for >5 
adenomas
Colorectal cancer At diagnosis Pretreatment colonoscopy; then 
at 12 mo after curative 
resection; then colonoscopy 
after 3 y; then colonoscopy 
every 5 y, if no new lesions
Ulcerative colitis, 
Crohn's colitis
At diagnosis; then 
after 8 y for 
pancolitis, after 15 
y for left-sided 
colitis
Colonoscopy with multiple 
biopsies every 1–2 y
FAP 10–12 y Annual flexible sigmoidoscopy
Upper endoscopy every 1–3 y 
after polyps appear
Attenuated FAP 20 y Annual flexible sigmoidoscopy
Upper endoscopy every 1–3 y 
after polyps appear
HNPCC 20–25 y Colonoscopy every 1–2 y
Endometrial aspiration biopsy 
every 1–2 y
Familial 
colorectal cancer 
first-degree 
relative
40 y or 10 y 
before the age of 
the youngest 
affected relative
Colonoscopy every 5 y
Increase frequency if multiple 
family members are affected, 
especially before 50 y
FAP = familial adenomatous polyposis; FOBT = fecal occult blood 
testing; HNPCC = hereditary nonpolyposis colon cancer.
TNM Staging of Colorectal Carcinoma
Tumor 
stage (T)
Definition
TX Cannot be assessed
T0 No evidence of cancer
Tis Carcinoma in situ
T1 Tumor invades submucosa
T2 Tumor invades muscularis propria
T3 Tumor invades through muscularis propria into 
subserosa or into nonperitonealized pericolic or 
perirectal tissues
T4 Tumor directly invades other organs or tissues or 
perforates the visceral peritoneum of specimen
Nodal stage (N)
NX Regional lymph nodes cannot be assessed
N0 No lymph node metastasis 
N1 Metastasis to one to three pericolic or perirectal lymph 
nodes
N2 Metastasis to four or more pericolic or perirectal lymph 
nodes
N3 Metastasis to any lymph node along a major named 
vascular trunk
Distant metastasis (M)
MX Presence of distant metastasis cannot be assessed
M0 No distant metastasis
M1 Distant metastasis present
TNM Staging of Colorectal Carcinoma and 5-Year Survival
Stage TNM 5-Y Survival (%)
I T1–2, N0, M0 70–95
II T3–4, N0, M0 54–65
III Tany, N1–3, M0 39–60
IV Tany, Nany, M1 0–16
Stage-Specific Therapy
Stage 0 (Tis, N0, M0)
The presence of high-grade dysplasia increases the risk of finding 
an invasive carcinoma within the polyp; for this reason, these polyps 
should be excised completely and pathologic margins should be free of 
dysplasia. 
Stage I: The Malignant Polyp (T1, N0, M0)
Treatment of a malignant polyp is based upon the risk of local 
recurrence and the risk of lymph node metastasis; the risk of lymph 
node metastases depends primarily upon the depth of invasion. Invasive 
carcinoma in the head of a pedunculated polyp with no stalk 
involvement carries a low risk of metastasis (<1%); and may be 
completely resected endoscopically. Invasive carcinoma in a sessile 
polyp extends into the submucosa and is usually best treated with 
segmental colectomy.
Stages I and II: Localized Colon Carcinoma (T1–3, N0, M0)
The majority of patients with stages I and II colon cancer will be 
cured with surgical resection; adjuvant chemotherapy has been 
suggested for selected patients with stage II disease (young patients, 
tumors with "high-risk" histologic findings).
Stage III: Lymph Node Metastasis (Tany, N1, M0)
Patients with lymph node involvement are at significant risk for 
both local and distant recurrence; and adjuvant chemotherapy has been 
recommended routinely in these patients. 5-fluorouracil based regimens 
(with levamisole or leucovorin) reduce recurrences and improve 
survival in this patient population; newer chemotherapeutic agents such 
as capecitabine, irinotecan, oxaliplatin, angiogenesis inhibitors and 
immunotherapy also show promise.
Stage IV: Distant Metastasis (Tany, Nany, M1)
Survival is extremely limited in stage IV colon carcinoma. Highly 
selected patients with isolated, resectable metastases may benefit from 
resection (metastasectomy). Commonest site of metastasis is the liver; 
of these, 20% are potentially resectable for cure; survival is improved in 
these patients (20 to 40% 5-year survival) when compared to patients 
who do not undergo resection. All patients require adjuvant 
chemotherapy. All other patients with stage IV disease cannot be cured 
surgically; and therefore, the focus of treatment should be palliation. 
Resection of the primary tumor has been recommended to prevent 
complications such as obstruction and bleeding. 
Follow-Up and Surveillance
Patients treated for colorectal cancer, are at risk for the 
development of recurrent disease (either locally or systemically) or 
metachronous disease (a second primary tumor). Metachronous cancers 
should be preventable by using surveillance colonoscopy to detect and 
remove polyps before they progress to invasive cancer. A colonoscopy 
should be performed within 12 months after the diagnosis of the original 
cancer and should be repeated every 3 to 5 years thereafter.
CEA often is followed every 2 to 3 months for 2 years. CT scans 
are done if CEA is elevated. More intensive surveillance is appropriate 
in high-risk patients such as those with possible HNPCC syndrome or 
T3 N + cancers.
Solitary rectal ulcer 
Solitary rectal ulcer syndrome is usually associated with internal 
intussusception. The symptoms are pain, bleeding, mucus discharge, or 
outlet obstruction. In solitary rectal ulcer syndrome, one or more ulcers 
are present in the distal rectum, usually on the anterior wall. 
Invetigations to  be done are anorectal manometry, defecography, and 
colonoscopy or barium enema to exclude other diagnoses. Biopsy of an 
ulcer or mass is essential to exclude malignancy. Conservative therapy 
(high-fiber diet, defecation training to avoid straining, and laxatives or 
enemas) is effective in the majority of patients. Surgery is reserved for 
highly symptomatic patients for whom all other medical interventions 
have failed.
LOWER GASTROINTESTINAL ENDOSCOPY
Indications for colonoscopy – generally indicated according to the 
2000 ASGE guidelines6
Hematochezia 
Clinically signiﬁcant diarrhoea of unexplained origin 
Irritable bowel syndrome or chronic abdominal pain: colonoscopy done 
once to rule out organic disease 
Inflammatory bowel disease
Unexplained iron deﬁciency anaemia 
Surveillance for patients who underwent removal polyp
Colonoscopy to remove synchronous neoplastic lesions at or around 
time of curative resection of cancer followed by colonoscopy at 3 years 
and 3-5 years thereafter to detect metachronous cancer
Evaluation of an abnormality on barium enema or other imaging study, 
which is likely to be clinically signiﬁcant, such as a ﬁlling defect or 
stricture
Presence of fecal occult blood
Examination to evaluate the entire colon for synchronous cancer or 
neoplastic polyps in a patient with treatable cancer or neoplastic polyp
Excision of colonic polyp
Balloon dilation of stenotic lesions (e.g., anastomotic strictures) 
Melena after an upper GI source has been excluded 
In patients with ulcerative or Crohn's pancolitis eight or more years' 
duration or left sided colitis or more years' duration every 1-2 years with 
systematic biopsies to detect dysplasia
Treatment of bleeding from such lesions as vascular malformation, 
ulceration, neoplasia, and polypectomy site (e.g., electrocoagulation, 
heater probe, laser or injection therapy)
Family history of sporadic colorectal cancer before the age of 60: 
colonoscopy every 5 years beginning at the age of 10 years earlier than 
the affected relative or every three years if adenoma is found
Intraoperative identiﬁcation of a lesion not apparent at surgery 
Family history of hereditary non-polyposis colorectal cancer: 
colonoscopy every two years beginning at the age of or ﬁve years 
younger than the earliest age of diagnosis of colorectal cancer. Annual 
colonoscopy beginning at the age of 40
Palliative treatment of stenosing or bleeding neoplasms (e.g., laser, 
electrocoagulation, stenting)
Indications for colonoscopy – generally not indicated according 
to the 2000 ASGE guidelines6
Chronic, stable, irritable bowel syndrome or chronic abdominal 
pain
Routine follow-up of inﬂammatory bowel disease 
Acute diarrhea 
Metastatic adenocarcinoma of unknown primary site in the absence 
of colonic signs or symptoms when it will not inﬂuence management 
Upper GI bleeding or melena with a demonstrated upper 
gastrointestinal source
BOWEL PREPARATION FOR LOWER GI ENDOSCOPY
Accuracy of diagnosis and safety of the procedure depends on the 
ability to see the colonic lumen clearly which requires a good bowel 
preparation.7 The ideal preparation for lower gastrointestinal endoscopy 
would be a empty colon without faecal material; with no gross 
histological alteration of the colonic mucosa. The ideal preparation 
should not cause any discomfort for the patient or alterations in fluids 
and electrolytes; and should not be expensive; however none of the 
preparations currently available meet all of these requirements.
REGIMENS FOR BOWEL PREPARATION FOR 
COLONOSCOPY
Diet
Dietary regimens ARE clear liquids and low-residue foods during 
one to four days prior to the procedure. It also includes oral cathartic 
and/or additional cathartic enemas a day before the procedure. Tap 
water enemas are given on the morning of the procedure and also 
occasionally on the evening before the procedure. 
Enemas
Tap water or sodium phosphate enemas are administered on the 
evening before or the morning of the procedure. 
PEG (electrolyte lavage solution)
PEG, a nonabsorbable solution that passes through the bowel 
without any net absorption or secretion is used on the morning of the 
procedure or the previous evening. There is no significant fluid and 
electrolyte shifts. But large volumes (2-4 litres) are required to achieve a 
cathartic effect.
Sulphate-free PEG (SF-PEG)
PEG-based lavage solutions without sodium sulfate was 
developed by Fordtran et al basically to improve the palatability, smell 
and taste of PEG solutions. The improved tastes were the result of a 
decrease in potassium concentration; increase in chloride concentration; 
and also complete absence of sodium sulphate. 
Bisacodyl
Bisacodyl is a poorly absorbed diphenylmethane which stimulates 
colonic peristalsis. It shortens the duration of whole gut irrigation. But 
there is no significant difference in colon cleansing was identified. 
Inadequate bowel preparation
Inadequate bowel preparation for colonoscopy can result in 
missed lesions, cancelled procedures, increased procedural time, and a 
potential increase in complication rates.
INFORMED CONSENT
The essential elements in the informed consent8 are
1. The patient’s pertinent medical diagnosis and test results.
2. The nature of the proposed procedure.
3. The reason the procedure is being suggested.
4. The benefits of the procedure.
5. The risks and complications of the procedure, including the relative 
incidence and severity, which would be material to the patient’s 
decision-making process.
6. Reasonable alternatives to the proposed procedure.
7. The patient’s prognosis if the treatment or test is declined.
PROCEDURE
During the procedure the patient is administered 
a sedative intravenously. Agents used for sedation are fentanyl and 
midazolam.9 Meperidine can also be used as an alternative to fentanyl, 
but complications such as seizures makes it second line drug to fentanyl 
and midazolam.9 Propofol can be used in alternative to midazolam, 
which gives the patient quicker recovery. It is gaining wider use, but 
requires closer monitoring of respiration. A meta-analytic study 
has found that playing music improves patient tolerability of the 
procedure.10 The procedure starts with patient in comfortable left lateral 
decubitus position. The first step is to do a thorough digital rectal 
examination (DRE) to assess the tone of the sphincter; and to determine 
if preparation has been adequate. The colonoscope or the sigmoidoscope 
is then passed through the anus, the rectum, the sigmoid colon, 
descending colon, the splenic flexure, the transverse colon, the 
ascending colon, the cecum and through the ileo-caecal valve to 
the terminal ileum. The endoscope has a twistable and mobile tip and 
separate channels each for instrumentation, insufflation of air, suction, 
camera and light. The bowel insufflated with air to maximize visibility 
which gives a sense of discomfort and sense of defaecation to the 
patient. During the procedure, the mucosal and vascular pattern of the 
entire large is carefully examined for any pathology. Suspicious lesions 
can be biopsied. In most experienced hands, the procedure can be 
completed in 10 minutes in 95% of cases. The difficulties encountered 
are tight turns and redundancy in areas of the colon that are not fixed, 
loops may form in which advancement of the endoscope creates a 
"bowing" effect that causes the tip to actually retract. This results in 
discomfort due to stretching of the colon and its mesocolon.  This can be 
manoeuvred pulling the endoscope backwards while torquing the 
instrument. Alternatively, the position of the patient can be changed and 
external hand pressure over the abdomen can often straighten the 
endoscope to allow the scope to move forward. Looping of the scope is 
often cited as a cause for an incomplete examination. A closer visual 
inspection is then often performed upon withdrawal of the endoscope 
over the course of 20 to 25 minutes. 
Figure 
On an average the procedure takes 20
the indication and findings. After the 
usually allowed to let the sedative wear off.
can take an estimate of 30
COMPLICATIONS
Although up to 33% of patients report at least one minor, 
transient GI symptom after colonoscopy, 
uncommon. Over 85% of the serious colonoscopy complications are 
reported in patients undergoing colonoscopy with polypectomy.
19 COLONOSCOPY SETUP
–30 minutes depending on 
procedure some recovery time is 
9 Outpatient recovery time 
–60 minutes. 
serious complications are 
11, 12
Abdominal discomfort/ Pain
The most commonly reported complications of colonoscopy are 
bloating (25%) and abdominal pain and/or discomfort 5% to 11%.11, 12
This can be avoided by avoiding and reducing endoscope looping and 
minimizing air insufflation should help reduce these symptoms.
Cardiopulmonary Complications
Cardiopulmonary complications have been defined to include 
events ranging from minor fluctuations in oxygen saturation or heart 
rate, to significant complications including respiratory arrest, cardiac 
arrhythmias, myocardial infarction, and shock.14 The risk of 
cardiopulmonary events associated with colonoscopy is increased in old 
age and in the presence of comorbidities.14 Appropriate pre-endoscopic 
assessment of cardiac status may reduce cardiopulmonary complications 
by ensuring that high-risk patients are co-managed with other specialists 
(eg, cardiology, anesthesiology); monitoring before, during, and after 
the procedure also may reduce the risk of complications.
Perforation
Colonic perforation may be due to mechanical forces against the 
bowel wall, barotrauma, or as a direct result of therapeutic procedures.13
Early symptoms of perforation include persistent abdominal pain and 
abdominal distension; later, patients may develop peritonitis. Plain 
radiographs of the chest and abdomen may demonstrate air under 
diaphragm, although CT scans have been shown to be superior to the 
upright chest film.
Haemorrhage
Hemorrhage is most often associated with therapeutic procedures 
such as polypectomy, although it can occur during diagnostic 
colonoscopy.13 In polypectomy, hemorrhage may occur immediately or 
can be delayed for several weeks after the procedure. A number of large 
studies have reported hemorrhage in 1 to 6 per 1000 colonoscopies 
(0.1%-0.6%). The rate of GI hemorrhage was significantly different 
with or without polypectomy: 2.1 per 1000 procedures coded as 
screening without polypectomy and 3.7 per 1000 for procedures coded 
as diagnostic without polypectomy, compared with 8.7 per 1000 for any 
procedures with polypectomy.
Postpolypectomy electrocoagulation syndrome 
It is due to electrocoagulation injury to the bowel wall that 
induces a transmural burn which results in localized peritonitis without 
evidence of perforation on radiographic studies. The incidence of this 
complication varies widely from 3 per 100,000 (0.003%) to 1 in 1000 
(0.1%).
Infection
Transient bacteremia after colonoscopy occurs in approximately 
4% of procedures, with a range of 0% to 25%; though signs or 
symptoms of infection are rare.
Gas Explosion
Explosive complications of colonoscopy are rare, reported 9 cases 
in 2007 review; each resulting in colonic perforation and, in one case, 
death.15 Gas explosion occurs when combustible levels of hydrogen or 
methane gas are present in the colonic lumen, oxygen is present, and 
electrosurgical energy is used
Miscellaneous complications
Miscellaneous complications of colonoscopy are splenic rupture, 
acute appendicitis, diverticulitis, subcutaneous emphysema, and 
intraabdominal hemorrhage. Chemical colitis may occur if 
glutaraldehyde, used during disinfection, has not been adequately rinsed 
from the endoscope.
AIM AND OBJECTIVES OF THE STUDY
1. To evaluate the spectrum of clinical findings in lower 
gastrointestinal endoscopy in patients presenting with altered 
bowel habits, bleeding per rectum and abdominal pain and to 
evaluate its diagnostic yield. 
2. To analyze the symptomatology in colorectal carcinoma.
MATERIALS AND METHODS:
PLACE OF STUDY:
Department of General Surgery,
Government Stanley Medical College and Hospital.
DURATION:
JULY 2013 TO DEC 2013
STUDY DESIGN:
Prospective study
SAMPLE SIZE: 100 CASES
INCLUSION CRITERIA:
1. Patients presenting with altered bowel habits, lower 
abdominal pain and/or bleeding per rectum.
2. Patients who are diagnosed to have haemorrhoids, fistula in 
ano and fissure in ano to rule out primary predisposing 
pathology for the above conditions and to rule out other 
lower GI pathology.
EXCLUSION CRITERIA:
 Patients who are not fit for colonoscopy.
 Patients not willing for lower GI endoscopy.
 Patients with previously established diagnosis.
METHODOLOGY:
 The first 100 patients presenting with features of lower abdominal 
pain, altered bowel habits and/or bleeding per rectum will be enrolled in 
the study as per the inclusion and exclusion criteria. 
 After obtaining informed consent the patients are subjected to a 
detailed history taking & clinical examination (annexure 1)
 Baseline investigations and cardiac workup for patients >50 years 
are done to assess the fitness of the patient to undergo lower GI 
endoscopy.
 Findings that will be considered significant would be 
premalignant and malignant lesions, inflammatory bowel disease and 
other colitis, stricture (benign & malignant), angiodysplasia. 
 Those that will not be considered significant will be hemorrhoids, 
fissure in ano and fistula in ano.
 The indications of colonoscopy and the findings in the lower GI 
endoscopy will be recorded and analysed to evaluate the spectrum of 
diseases occurring in such patients.
 Diagnostic yield will be defined as the ratio between significant 
findings detected on colonoscopy and the total no. of procedures 
performed for the specified indication.
 The results are analyzed using Microsoft Excel for tabular 
transformation and graphical representation.
OBSERVATION AND RESULTS
This study was conducted in the Department of General Surgery 
in Government Stanley Medical College and Hospital, Chennai over a 
period of one year. The 100 patients presenting with complaints of 
bleeding per rectum, altered bowel habits, lower abdominal pain or 
combination of these symptoms, who fulfilled the inclusion criteria were 
enrolled in this study after obtaining informed consent
Table 1: Sex distribution of patients undergoing endoscopy                            
SEX NO. OF PATIENTS PERCENTAGE %
MALE 68 68%
FEMALE 32 32%
TOTAL 100 100%
Out of 100 patients enrolled for the study 68 patients were male 
and 22 patients were female
Male:Female ratio – 2.1:1
Figure 1: Sex distribution
Table 2: Age distribution of patients undergoing endoscopy
AGE RANGE IN 
YEARS
NO. OF PATIENTS PERCENTAGE %
20-40 YRS 32 32%
41-60 YRS 44 44%
>60 YRS 24 24%
TOTAL 100 100%
The age group of patients enrolled in this study ranges from 20-80 
yrs. Most patients (85%) fall in the age group of 20-60 yrs. 15% of 
patients were above 60 yrs.
SEX DISTRIBUTION
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Figure 2: Age distribution of patients undergoing endoscopy
Table 3: Lower GI endoscopy
PROCEDURE NO. OF PATENTS PERCENTAGE%
SIGMOIDOSCOPY 32 32%
COLONOSCOPY 68 68%
TOTAL 100 100%
Of the two lower GI endoscopic procedures, colonoscopy (68%) 
is more commonly done than sigmoidoscopy(32%).
Figure 3: Lower GI endoscopy
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Table 4: Endoscopy results
FINDINGS NO. OF PATIENTS PERCENTAGE%
NORMAL STUDY 50 50%
PATHOLOGICAL FINDING 44 44%
INCOMPLETE PROCEDURE 6 6%
TOTAL 100 100%
50% of the patients who underwent endoscopy found to have no 
abnormalities. Positive pathological findings were found in 44% of the 
patients. Procedure was not completed or deferred in 6% of patients.
Figure 4: Endoscopy results
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Table 5: Diagnostic pattern observed in the study
PATHOLOGICAL 
FINDING
NO. OF PATIENTS PERCENTAGE
POLYPS 11 25%
MALIGNANCY 25 56%
ULCERATIVE COLITIS 2 4.5%
TUBERCULOSIS 2 4.5%
SOLITARY RECTAL 
ULCER
2 4.5%
DIVERTICULAR DISEASE 2 4.5%
Colorectal malignancy is the most common disease found in the 
study group (56%). Other major findings in the study group are 
50 44
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ENDOSCOPY RESULTS
ENDOSCOPY RESULTS
NORMAL STUDY 
PATHOLOGICAL FINDING 
PROCEDURE INCOMPLETE 
colorectal polyps (25%); ulcerative colitis (4.5%); tuberculosis (4.5%); 
diverticular disease (4.5%); solitary rectal ulcer (4.5%).
Figure 5: Diagnostic pattern observed in the study
Table 6: Age distribution in malignancy
AGE RANGE IN 
YEARS
NO. OF PATIENTS PERCENTAGE%
20-40 YRS 8 32%
41-60 YRS 11 44%
>60  YRS 6 24%
TOTAL 25 100%
DIAGNOSTIC PATTERN 
11
25
2
2
2 2 POLYPS 
MALIGNANCY 
ULCERATIVE COLITIS 
TUBERCULOSIS 
DIVERTICULITIS 
SOLITARY RECTAL ULCER 
Most common age group of presentation of malignancy is 40-60 
yrs (44%). Occurrence of malignancy in age group 20-40 yrs is 
strikingly 32%; in age group more than 60 yrs is 24%.
Figure 6: Age distribution in malignancy
Table 7: Sex distribution in malignancy
SEX NO. OF PATIENTS PERCENTAGE%
MALE 15 60%
FEMALE 10 40%
TOTAL 25 100%
Incidence of colorectal malignancy is more common in males 
than females. Male:Female ratio is 3:2
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Figure 7: 
Table 8: Site of involvement of malignancy
SITE OF 
INVOLVEMENT
ANAL CANAL
RECTUM
RECTOSIGMOID
SIGMOID COLON
DESCENDING COLON
TRANSVERSE COLON
ASCENDING COLON
CAECUM
TOTAL
40%
Sex distribution in malignancy
NO. OF PATIENTS PERCENTAGE%
3 12%
11 44%
2 8%
5 20%
2 8%
0 0%
1 4%
1 4%
25 100%
60%
MALE
FEMALE
Most common site of involvement of colorectal malignancy is 
rectum (44%), followed by sigmoid (20%). Involvement of anal canal is 
seen in 12%; recctosigmoid 8%; descending colon 8%; ascending colon 
4%; and caecum 4%
Figure 8: Site of involvement of malignancy
Table 9: Symptomatology in malignancies
SYMPTOM NO. OF PATIENTS PERCENTAGE%
BLEEDING P/R 21 84%
ALTERED BOWEL 
HABITS
10 40%
LOWER ABDOMINAL 
PAIN
14 56%
SITE OF INVOLVEMENT OF MALIGNANCY
12%
44%
8%
20%
8%
0%
4%
4%
ANAL CANAL 
RECTUM 
RECTOSIGMOID 
SIGMOID 
DESCENDING COLON 
TRANSVERSE COLON 
ASCENDING COLON 
CAECUM 
Bleeding p/r is seen in 84% of cases of colorectal 
Altered bowel habits are seen in 40% of cases. Lower abdominal pain is 
seen in 56% of cases.
Figure 9: Symptomatology in malignancies
Table 10: Diagnostic yield of lower GI endoscopy
INDICATION
BLEEDING P/R
ALTERED BOWEL 
HABITS
LOWER 
ABDOMINAL PAIN
SCREENING
MORE THAN 1 
INDICATION
0
20
40
60
80
100
BLEEDING 
P/R
malignancies. 
NO. OF 
PATIENTS
NO. OF 
ABNORMALITIES
DIAGNOSTIC 
YIELD
45 14 31.1%
5 1 20%
10 2 20%
26 5 19.2%
30 26 86.6%
ALTERED 
BOWEL 
HABITS
LOWER 
ABDOMINAL 
PAIN
NO. OF 
PATIENTS
Figure 10: Diagnostic yield of lower GI endoscopy
Figure 11: Diagnostic yield of lower 
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Table 12: Complications of the Procedure observed in the Study
COMPLICATION NO. OF 
PATIENTS
PERCENTAGE% CONSEQUENCES
MINOR 
COMPLICATIONS
(ABDOMINAL 
DISCOMFORT)
6 6 PROCEDURE 
COULD NOT BE 
COMPLETED
MAJOR 
COMPLICATIONS
NIL - -
Complications observed in the study is almost nil, with only 
minor abdominal discomfort seen in 6 patients which made us to 
abandon the procedure.
DISCUSSION
Over the last two decades, there is remarkable development in 
investigations for diseases of the lower GI tract; and colonoscopy has 
become the most commonly performed procedure for the diagnosis of 
diseases of the lower GI tract and screening of screening of colorectal 
cancer. The increasing availability of colonoscopy has led to 
inappropriate and overuse of this procedure which ranges from 15-35% 
in different studies, raising controversy regarding open access 
endoscopy versus a strict selection criteria for the procedure. However, 
by adhering to strict selection criteria, we are bound to miss some 
patients with significant and potentially treatable diseases. To overcome 
the controversy, selection of patients based on diagnostic yield of 
procedure for the specified indication can be done.
Patients with any of the three indications such as lower abdominal 
pain, altered bowel habits and bleeding p/r or a combination of these 
indications are subjected to lower GI endoscopy. Screening for patients 
with haemorrhoids, fissure in ano or fistula in ano to rule out 
predisposing causes and other pathology are also subjected to 
endoscopy. Another uncommon indication is mass in the right or left 
iliac fossa. Diagnostic yield of the indications are calculated.
In our study average age of the patients were 45 years which was 
similar to other studies such as Iqbal et al18 and Al-Shamali et al19. The 
procedure was more commonly done in males 68% and this is slightly 
higher compared to other studies in which the percentage of females 
was slightly higher. This may be attributed to the fact that female in our 
country are reluctant to undergo examination of perineum.
Out of the lower GI endoscopic procedures colonoscopy was 
more commonly was more commonly done (68%) than sigmoidoscopy 
(32%) which was comparably higher than the previous study by 
S.K.Sahu et al17 in which colonoscopy is performed in 53% of patients 
and sigmoidoscopy in 47% of patients. This is due the fact that in our 
study we used sigmoidoscopy only for screening of patients with 
haemorrhoids and fistula in ano.
Pathological findings were seen in 44% of patients which nearly 
matches with S.K.Sahu et al17 (48%) and grossly higher than Al-
Shamali et al19 (21%). Bleeding p/r (45%) was the primary indication in 
our study, contrary to Al-Shamali et al19 in which lower abdominal pain 
was the primary indication (53%). The diagnostic yield of colonoscopy 
for bleeding p/r was 31.1% which was very low compared to Berkowitz 
et al16 (70%) and Al-Shamali et al19 (47%). Low yield of rectal bleeding 
can be attributed to the fact that haemorrhoids and fissure in ano are not 
considered as positive findings in our study.
The second common indication found in our study was patients 
presenting with more than one symptom of lower GI diseases. The 
diagnostic yield of colonoscopy for this group of patients was an 
astonishing 86.6%. This was not included in any of the previous studies 
of evaluating the diagnostic yield.
Lower abdominal pain as the only complaint is seen in 10% of 
patients which had a diagnostic yield of 20%. The low yield and less 
number of patients are due to the fact that most of the patients who had 
lower abdominal pain also had other symptoms and they are included in 
‘more than 1 indication’ category. On the contrary, lower abdominal 
pain was the primary indication in study by Al-Shamali et al19 (53%). It 
had a low yield of 7% for abnormalities and 0.3% for malignancies.
Altered bowel habits as the indication is seen in only 5% of 
patients and it had a diagnostic yield of 20%. In study by Al-Shamali et 
al19, it had a yield of 35%. The low yield in our study is again
contributed to the fact that most patients had other symptoms also. 
Screening of patients with haemorrhoids and fistula in ano also yielded 
pathological finding in 20% and colorectal cancer in 11%.
The common age group of presentation for colorectal malignancy 
was 40-60 years and the mean age was 45.6 years. The incidence among 
people <40 years was strikingly 32% which is significantly higher 
compared to the literature evidence (10%). The reason for the higher 
incidence among younger people though not known can be attributed to 
environmental, dietary and genetic factors, which mandates further 
analysis. 
Males are more commonly affected by colorectal malignancy 
(60%) in our study which correlates with literature value (57.2%). The 
most common site of involvement of malignancy was rectum (44%) 
which correlates with literature value of 45-55%. The current trend of 
shift towards right sided colon was not observed in our study (8%).
Of the 25 patients with colorectal malignancy 18 patients (72%) 
had more than one symptom which shows that it is the most common 
presentation of colorectal cancer. Rectal bleeding was seen in 84% of 
patients which shows that it is the commonest symptom in colorectal 
malignancy.
Complication rate reported for colonoscopy is 2.8 per 1000 as per 
Whitlock et al20. Minor, transient GI discomfort was seen in 33% of 
patients as per Dominitz JA et al11, 12. But in our study there were no 
major complication and only 6% had significant abdominal discomfort 
which mandates procedure stoppage. The low complication rate is 
because there were no therapeutic procedures done in our study.
LIMITATIONS OF THE STUDY
 Small sample size in the study
 Most patients present with multiple lower GI symptoms which 
interferes with accurate estimation of diagnostic yield of the 
procedure for individual symptoms
 Only sigmoidoscopy is done for screening the patients with 
haemorrhoids and fistula in ano which makes the study of the colon 
incomplete.
 Unusually high incidence of colorectal cancer in younger age group 
could not be explained.
 Complication rate is not assessed correctly as therapeutic procedures 
were not done which may have higher complication and also patients 
with cardiac diseases are not included in study.
CONCLUSION
Colonoscopy is the most important tool in the evaluation and 
diagnosis of diseases of lower gastrointestinal tract. The diagnostic yield 
of lower GI endoscopy in our study is as high as 44%, whereas the 
complication rate of diagnostic endoscopy is almost nil except minor 
abdominal discomfort. The diagnostic yield for colorectal cancer is 
highest for patients presenting with multiple lower GI symptoms. Rectal 
bleed is the most common presenting symptom in colorectal 
malignancy. Screening of patients with just a sigmoidoscopy who 
presents with common diseases of the anorectum should also be 
considered as this might be just the tip of the iceberg with potentially 
life threatening disease inside.
So from this study we conclude that lower GI endoscopy is 
mandatory in patients presenting with multiple lower GI symptoms and 
bleeding per rectum; and screening with sigmoidoscopy should 
preferably be considered in patients presenting with common diseases of 
the anorectum. In patients presenting with low yield symptoms, 
judicious decision making is required to either subject the patient to 
endoscopy or other less invasive investigations.     
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PROFORMA
SL. NO:
NAME : AGE /SEX: IP NO:
ADDRESS WITH CONTACT NUMBER:
DATE OF ADMISSION:
DATE OF      DISCHARGE:
HISTORY OF PRESENTING ILLNESS:
H/O abdomen pain- onset
duration
progression
radiation
aggravating/relieving factors
H/O constipation
H/O mass descending per rectum
H/O melena, hematochezia
H/O vomiting, hematemesis
H/O altered bowel habits
H/O fever
H/O jaundice
H/O loss of appetite, loss of weight
PAST HISTORY:
H/O  Diabetes mellitus/hypertension/asthma/TB/epilepsy/cardiac illness
H/o similar episodes in the past, if any:
H/o major illness/ hospital admissions, if any
PERSONAL HISTORY:
Whether a smoker or an alcohol consumer
FAMILY HISTORY:
TREATMENT HISTORY:
CLINICAL EXAMINATION:
General examination:
Systemic examination:
CVS
RS
CNS
Per abdomen
Per rectal examination and Proctoscopy
Clinical diagnosis:
INVESTIGATIONS:
Complete blood count
Random blood sugar
Renal function test: Blood urea, serum creatinine
Liver function test
Chest X ray, ECG
Lower Gastrointestinal endoscopy
FINAL DIAGNOSIS:

